Delenex Therapeutics AG

Delenex Therapeutics AG is a recently formed biotech company based in Zürich-Schlieren. It aims to deliver the next generation of antibody fragment therapeutics in diseases with high unmet medical need. Based on a validated antibody technology platform Delenex comprises a portfolio of existing project, including clinical-stage, assets with ambitious plans for new programmes in CNS disease, dermatology and other serious conditions.
To complement the team as the company operations develop, we are looking to fill a new R&D position:

Details


Adresse:
Delenex Therapeutics AG

Wagistrasse 23
8952 Schlieren
Schweiz
Arbeitsgebiet:
Klinische Forschung
Expansion:
national